Molecular modeling, synthesis and biological evaluation of caffeic acid based Dihydrofolate reductase inhibitors

Renu Sehrawat, Ritu Pasrija, Priyanka Rathee, Deepika Kumari, Anurag Khatkar · 2024

Read Molecular modeling, synthesis and biological evaluation of caffeic acid based Dihydrofolate reductase inhibitors by Renu Sehrawat, Ritu Pasrija, Priyanka Rathee, Deepika Kumari, Anurag Khatkar (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11658390.txt.

Description

Renu Sehrawat and co-authors designed new drug candidates from caffeic acid, a plant compound, aimed at an enzyme that cancer and microbes both depend on. The enzyme, DHFR, drives the folate chemistry cells need to grow and divide; blocking it is the strategy behind the established drug methotrexate. The team modeled, synthesized, and tested a series of derivatives against the enzyme, bacteria, and breast cancer cells.

One compound, CE11, blocked DHFR about four times more strongly than methotrexate and docked into the same pocket. It also killed breast cancer cells at low doses. Two sibling compounds beat standard antibiotics against several bacteria, including resistant problem species. Computer docking explained the grip: snug fits in greasy pockets plus a few well-placed hydrogen bonds.

Catalog record

CREATORRenu Sehrawat, Ritu Pasrija, Priyanka Rathee, Deepika Kumari, Anurag Khatkar
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11658390

Browse the full library · About the Tower of Babel